Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05588609 |
| Title | Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Merus N.V. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| The Oncology Institute of Hope & Innovation | Whittier | California | 90603 | United States | Details | |
| Florida Cancer Specialists | Lake Mary | Florida | 32746 | United States | Details | |
| The Center for Cancer and Blood Disorders | Bethesda | Maryland | 20817 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| TriHealth Cancer Institute | Cincinnati | Ohio | 45220 | United States | Details | |
| University Hospitals - Seidman Cancer Center | Cleveland | Ohio | 44106 | United States | Details | |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | United States | Details |